Popular Anti Cancer Drug Rituxan Presents Many Risks to Unwary Patients

LOS ANGELES - OCT 6:  Linsey Godfrey cancer survivor ribbon tattoo attends the Light The Night Walk to benefit The Leukemia & Lymphoma Society at Sunset Gower Studios on October 6, 2012 in Los Angeles, CA

LOS ANGELES – Cancer survivor ribbon tattoo

Rituxan, also known as Rituximab, has become a popular drug meant to combat lymphoma, or immune cancer. The drug has been used for other purposes, including for autoimmune anemia, MS, lupus, and rheumatoid arthritis. The immune suppressing effects of the drug have many purposes, but a significant risk, as well.

Linked to Multifocal Leukoencephalopathy

Unfortunately, Rituxan has also been linked to Progressive multifocal leukoencephalopathy, or PML– a rare infection of the brain. This disease can cause dizziness, lack of motor skills, vision issues, and other problems. PML has no known cure and could potentially lead to death. The drug is currently under investigation by the FDA.

Canada’s Warnings

Canadian officials have also issued a warning about other potential effects. There is also a risk of developing Toxic Epidermal Necrolysis, or TEN and Stevens-Johnson Syndrome, or SJS, both of which could be fatal.


Legal Assistance

If you or a loved one has taken Rituximab and have been acting differently or had neurological issues, please contact both your doctor and a professional attorney immediately.  Medical malpractice and product liability attorneys typically stand ready to assist victims and their families in holding the responsible parties accountable. Many of these legal representatives offer a no-pressure, free legal consultation, and help when you need it the most.